News McKesson Corporation

Equities

MCK

US58155Q1031

Pharmaceuticals

Market Closed - Nyse Other stock markets 04:00:02 2025-03-14 pm EDT			5-day change	1st Jan Change
650.43 ^USD	+1.05%		+0.96%	+14.13%

Mar. 14	Wells Fargo Adjusts Price Target on McKesson to $691 From $641, Maintains Equalweight Rating	MT
Mar. 07	Mckesson Insider Sold Shares Worth $5,684,059, According to a Recent SEC Filing	MT

Wells Fargo Adjusts Price Target on McKesson to $691 From $641, Maintains Equalweight Rating	Mar. 14	MT
Mckesson Insider Sold Shares Worth $5,684,059, According to a Recent SEC Filing	Mar. 07	MT
Leerink Partners Adjusts Price Target on McKesson to $732 From $690, Keeps Outperform Rating	Mar. 07	MT
Lumata Health Secures $23 Million Series B Funding Round Co-Led By Lrvhealth, Mckesson Ventures, Cencora Ventures	Mar. 05	RE
McKesson Corporation Presents at TD Cowen 45th Annual Healthcare Conference, Mar-04-2025 09:50 AM	Mar. 04
Mckesson Insider Sold Shares Worth $5,591,664, According to a Recent SEC Filing	Mar. 03	MT
Ex-dividend day	Mar. 02	FA
Mckesson Insider Sold Shares Worth $5,358,588, According to a Recent SEC Filing	Feb. 24	MT
Mckesson Insider Sold Shares Worth $5,382,514, According to a Recent SEC Filing	Feb. 18	MT
Baird Adjusts McKesson Price Target to $730 From $729, Maintains Outperform Rating	Feb. 18	MT
District Court Rules Employer's Withdrawal Liability Cannot Be Based On Post-Rehabilitation Plan Contribution Increases	Feb. 14	AQ
McKesson : Q3 2025 McKesson Corporation Earnings Conference Call Transcript	Feb. 07	PU
McKesson, AmerisourceBergen's Joint Motion to Dismiss Antitrust Case Granted by Pennsylvania Judge	Feb. 06	MT
McKesson : Third Quarter 2025 Earnings Call Transcript	Feb. 06	PU
McKesson : Q3 2025 McKesson Corporation Earnings Transcript	Feb. 06	PU
Leerink Partners Adjusts Price Target on McKesson to $690 From $667	Feb. 06	MT
Evercore ISI Adjusts Price Target on McKesson to $675 From $650	Feb. 06	MT
Baird Adjusts Price Target on McKesson to $729 From $693	Feb. 06	MT
McKesson's Board of Directors Elects Lynne Doughtie and Julie Gerberding as New Directors	Feb. 06	AQ
Deutsche Bank Adjusts McKesson Price Target to $663 From $628, Maintains Buy Rating	Feb. 06	MT
McKesson : Q3 2025 McKesson Corporation Earnings Conference Call Presentation	Feb. 05	PU
McKesson misses third-quarter revenue estimates	Feb. 05	RE
McKesson : McKessons Board of Directors Elects Lynne Doughtie and Julie Gerberding as New Directors	Feb. 05	PU
McKesson : Fiscal 2025 Third-Quarter Earnings Call Supplemental Slide Presentation	Feb. 05	PU
McKesson: Fiscal Q3 Earnings Snapshot	Feb. 05	AQ

e5f.YovEs3DVIMDEzkhr2Y0yEPkMWtyXHr-_udvhim4AyCI.FMmt5zmbQque4w0G7cxXJbtFE-_zbdf80eqUs0MznA8avL3dN4F3i7GkHQ

Become a member to access more news.

100% Free Registration

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News McKesson Corporation

Equities

MCK

US58155Q1031

Pharmaceuticals

Filters